CV9201 is another mRNA vaccine based on RNActive®, which encodes five NSCLC antigens, including melanoma antigen family C1 (MAGE-C1), MAGE family C2, New York esophageal squamous cell carcinoma 1 (NY-ESO-1), trophoblast glycoprotein (5T4), and survivin. Here, TPBG is linked to non-small cell lung carcinoma.